{
  "image_filename": "figure_p1_det_0_017.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p1_det_0_017.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_017",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "The image shows the top of page 1 of a clinical article titled \u201cRecombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age,\u201d listing authors and the beginning of the abstract, with introductory text about trivalent recombinant vaccines. does not support the claim Note: The visible content is limited to the article title, authors, and partial abstract; there is no mention of antigenic matching or WHO/FDA strain selection.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "The image shows the top of page 1 of a clinical article titled \u201cRecombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age,\u201d listing authors and the beginning of the abstract, with introductory text about trivalent recombinant vaccines.",
    "evidence_found": null,
    "reasoning": "does not support the claim",
    "confidence_notes": "The visible content is limited to the article title, authors, and partial abstract; there is no mention of antigenic matching or WHO/FDA strain selection."
  }
}